Valuation: INSTITUT

Market Cap 440.12Cr 5.17Cr 4.62Cr 4.3Cr 3.91Cr 7.37Cr 498.26Cr 7.42Cr 52Cr 20Cr 254.31Cr 19Cr 19Cr 817.43Cr P/E 2024
25.7x
P/E 2025 46.2x
Enterprise Value 463.57Cr 5.45Cr 4.86Cr 4.53Cr 4.12Cr 7.76Cr 524.81Cr 7.82Cr 55Cr 21Cr 267.86Cr 20Cr 20Cr 860.98Cr EV / Sales 2024
3.02x
EV / Sales 2025 2.7x
Free-Float
17.07%
Yield 2024 *
-
Yield 2025 2.02%
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Chief Investment Officer - -
Director TitleAgeSince
Director/Board Member 68 23/08/2010
Director/Board Member 47 09/01/2014
Director/Board Member 45 01/01/2011
Change 5-day change 1-year change 3-year change Capi.($)
+1.07%-0.92%+13.27%+24.79% 11TCr
+2.05%+0.47%+0.25%+77.09% 9.24TCr
+3.20%+2.30%+147.23%+877.11% 5.91TCr
+1.16%-5.45%-7.47%+56.12% 2.77TCr
-0.30%-2.29%+30.13%+88.78% 2.58TCr
+0.32%-0.05%+12.50%+54.10% 2.5TCr
+1.12%+1.43%-15.41%-3.74% 2.09TCr
+1.44%+1.55%+31.12%+331.44% 2.08TCr
-0.51%-3.36%-4.55%+33.79% 1.69TCr
Average +1.06%-1.81%+23.01%+171.05% 4.43TCr
Weighted average by Cap. +1.42%-2.04%+28.39%+186.25%

Financials

2024 2025
Net sales 152.15Cr 1.79Cr 1.6Cr 1.49Cr 1.35Cr 2.55Cr 172.25Cr 2.57Cr 18Cr 6.99Cr 88Cr 6.71Cr 6.57Cr 282.58Cr 171.62Cr 2.02Cr 1.8Cr 1.68Cr 1.53Cr 2.87Cr 194.29Cr 2.89Cr 20Cr 7.88Cr 99Cr 7.57Cr 7.41Cr 318.74Cr
Net income 21Cr 25.26L 22.54L 21L 19.11L 35.98L 24Cr 36.25L 2.54Cr 98.71L 12Cr 94.84L 92.79L 40Cr 9.7Cr 11.4L 10.17L 9L 9L 16.23L 11Cr 16.35L 1.14Cr 44.53L 5.6Cr 42.78L 41.86L 18Cr
Net Debt 20Cr 23.42L 20.89L 19.46L 17.71L 33.35L 23Cr 33.6L 2.35Cr 91.49L 12Cr 87.9L 86.01L 37Cr 23Cr 27.57L 24.59L 22.91L 20.85L 39.26L 27Cr 39.55L 2.77Cr 1.08Cr 14Cr 1.03Cr 1.01Cr 44Cr
Logo INSTITUT
Artgen Biotekh PAO is a Russia-based company engaged in the research and development and invesment in biotechnology. The Company develops and implements drugs, products or methods of treatment, diagnostic and prevention of diseases. The Company invests in assets engaged in development and commercialization of new drugs, medical devices, genetic diagnostics and research and other high-tech products and services related to biomedicine and healthcare. Artgen Biotekh PAO develops a platform for startups and companies to share knowledge related to science, research, production, marketing, business, regulations, patent and other fields. Some of the Company's products are Neovasculgen, a gene therapy drug, vaccines Tetraflubet and Betuvax and others.
Employees
-